血栓切除术后研究缺血性卒中血栓成分:我们能学到什么?
综述探讨血管内血栓切除术后获取的缺血性卒中血栓成分研究价值。血栓由纤维蛋白、血管性血友病因子、中性粒细胞胞外诱捕网及红细胞、血小板、白细胞、细菌等成分异质性构成,该复杂组成可能解释治疗局限,并有助于理解取栓成功率、溶栓、临床结局、卒中病因及影像学表现。
要点
- 卒中血栓成分复杂异质,含纤维蛋白、血管性血友病因子、中性粒细胞胞外诱捕网及多种细胞成分。
- 血栓成分研究可能解释取栓与溶栓的治疗局限,并为卒中管理提供新见解。
- 血栓特征与取栓成功率、临床结局、卒中病因及影像学表现具有潜在关联。
核心结论
- 缺血性卒中血栓由多种生化与细胞成分复杂异质构成,深入理解血栓特征可能改善卒中患者管理。
研究设计与样本
- 综述性文章,基于血管内血栓切除术后获取的患者血栓材料,汇总血栓成分分析的相关证据。
主要发现
- 卒中血栓含纤维蛋白、血管性血友病因子、中性粒细胞胞外诱捕网等生化成分,以及红细胞、血小板、白细胞、细菌等细胞成分。
- 血栓复杂成分可能解释治疗局限性,并可能为取栓成功率、溶栓、临床结局、卒中病因及影像学提供新见解。
临床怎么用
- 可利用取栓后获得的血栓材料进行成分分析,以辅助理解治疗反应、卒中病因及影像学表现。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The composition of ischemic stroke thrombi has gained an increasing amount of interest in recent years. The implementation of endovascular procedures in standard stroke care has granted researchers the unique opportunity to examine patient thrombus material. Increasing evidence indicates that stroke thrombi are complex and heterogenous, consisting of various biochemical (eg, fibrin, von Willebrand Factor, and neutrophil extracellular traps) and cellular (eg, red blood cells, platelets, leukocytes, and bacteria) components. This complex composition may explain therapeutic limitations and also offer novel insights in several aspects of stroke management. Better understanding of thrombus characteristics could, therefore, potentially lead to improvements in the management of patients with stroke. In this review, we provide a comprehensive overview of the lessons learned by examining stroke thrombus composition after endovascular thrombectomy and its potential relevance for thrombectomy success rates, thrombolysis, clinical outcomes, stroke etiology, and radiological imaging.
引用
- Staessens S, François O, Brinjikji W, et al. Studying Stroke Thrombus Composition After Thrombectomy: What Can We Learn? Stroke. 2021. PMID: 34517770. doi:10.1161/STROKEAHA.121.034289
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。